Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Nangaku · SciRah

Researcher profile · Semantic Scholar

M. Nangaku

Share profile

M. Nangaku — researcher profile on SciRah

h-index: 18
Works: 225
Citations: 2,884

Most-cited papers

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
R. Agarwal, Jennifer B. Green, H. Heerspink, J. Mann +11 more
2025New England Journal of Medicine216 citations Open access
Semantic Scholar
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics
R. Agarwal, Jennifer B. Green, H. Heerspink, J. Mann +11 more
2025Nephrology, Dialysis and Transplantation29 citations Open access
Semantic Scholar
Maintaining kidney health in aging societies: a JSN and ERA call to action
Alberto Ortiz, A. Kramer, Ivan Rychlík, M. Nangaku +13 more
2025Nephrology, Dialysis and Transplantation18 citations Open access
Semantic Scholar
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized Trial.
R. Agarwal, J. Green, H. Heerspink, J. McGill +11 more
2025Journal of the American College of Cardiology14 citations Open access
Semantic Scholar
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study
Takahiro Imaizumi, H. Komaba, Takayuki Hamano, M. Nangaku +8 more
2025Clinical Kidney Journal13 citations Open access
Semantic Scholar
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia
R. Agarwal, J. Green, H. Heerspink, J. Mann +13 more
2025American Society of Nephrology. Clinical Journal9 citations Open access
Semantic Scholar
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
A. Tanaka, M. Vaduganathan, T. Imai, Yosuke Okada +26 more
2025Cardiovascular Diabetology9 citations Open access
Semantic Scholar
Gender differences in the prescription of SGLT2 inhibitors in chronic kidney disease: A real‐world database study
Tatsuhiko Azegami, H. Kaneko, A. Okada, Yuta Suzuki +11 more
2025Diabetes, obesity and metabolism9 citations Open access
Semantic Scholar
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.
B. Neuen, V. Perkovic, R. Agarwal, D. Cherney +31 more
2026Journal of the American Medical Association (JAMA)8 citations Open access
Semantic Scholar
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial
M. Vaduganathan, Jennifer B. Green, H. Heerspink, Sung Gyun Kim +11 more
2025Nephrology, Dialysis and Transplantation8 citations Open access
Semantic Scholar
Changing paradigms of studies in kidney diseases.
Adeera Levin, A. Jauré, Dustin J. Little, Jane O. Schell +24 more
2025Kidney International7 citations Open access
Semantic Scholar
Validation of Sleep Measurements of an Actigraphy Watch: Instrument Validation Study
M. Waki, Ryohei Nakada, K. Waki, Ban Yuki +4 more
2025JMIR Formative Research6 citations Open access
Semantic Scholar
Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims database
Kazuki Aoyama, A. Okada, H. Kaneko, Tatsuhiko Azegami +11 more
2025Diabetes, obesity and metabolism6 citations Open access
Semantic Scholar
Metrics for Evaluating Telemedicine in Randomized Controlled Trials: Scoping Review
Yuka Sugawara, Y. Hirakawa, M. Iwagami, R. Inokuchi +2 more
2025Journal of Medical Internet Research5 citations Open access
Semantic Scholar
Lean body mass index and hypertension risk in men: a nationwide epidemiological cohort study
Tatsuhiko Azegami, H. Kaneko, A. Okada, Yuta Suzuki +10 more
2025Hypertension Research5 citations Open access
Semantic Scholar
Guatemala's resolution on kidney health: a historic opportunity.
Marcello Tonelli, M. Nangaku, Magdalena Machalska, Agnes Fogo +4 more
2025The Lancet5 citations Open access
Semantic Scholar
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both
A. Mottl, Charlie Scott, J. Green, H. Heerspink +9 more
2025Journal of the American Society of Nephrology5 citations Open access
Semantic Scholar
Insights into GLP-1 and insulin secretion mechanisms in pasireotide-induced hyperglycemia highlight effectiveness of Gs-targeting diabetes treatment
Junichiro Sato, Katsunori Manaka, Hirofumi Horikoshi, Maho Taguchi +5 more
2025Scientific Reports5 citations Open access
Semantic Scholar
Sex differences in the progression of cardiovascular–kidney–metabolic syndrome
Satoshi Taya, Kentaro Ejiri, H. Kaneko, Yuta Suzuki +15 more
2025European Heart Journal Open5 citations Open access
Semantic Scholar
Increasing Prescription of SGLT2 Inhibitors with Expanded Indications to the Elderly Population in Japan
Yasuhiro Oda, Hiroshi Nishi, Mariko Sekiguchi, Motoki Odawara +1 more
2025Kidney Diseases4 citations
Semantic Scholar
Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan
M. Nangaku, K. Sasaki, Jing Bi, Kiichiro Ueta +3 more
2025Advances in Therapy4 citations Open access
Semantic Scholar
Temporal trends in time toxicity of R-CHOP: a nationwide hospital-based database analysis in Japan
Hiroaki Araie, Tomohisa Seki, A. Okada, T. Yamauchi +5 more
2025Supportive Care in Cancer4 citations Open access
Semantic Scholar
Epigenetic memories induced by hypoxia in AKI-to-CKD transition
Giyoung Kwoun, M. Nangaku, I. Mimura
2025Clinical and Experimental Nephrology4 citations Open access
Semantic Scholar
Cardiovascular-kidney-metabolic syndrome stage predicts cardiovascular outcomes in cancer patients: a real-world data analysis of a nationwide epidemiological dataset
Toshiyuki Ko, Yuta Suzuki, H. Kaneko, A. Okada +12 more
2025European Heart Journal Open4 citations Open access
Semantic Scholar
Population attributable fraction of modifiable risk factors for incident hypertension: an analysis of large-scale epidemiological cohort
Masachika Nishikawa, Yuta Suzuki, Hidehiro Kaneko, A. Okada +15 more
2026Hypertension Research3 citations Open access
Semantic Scholar
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone
R. Agarwal, R. Correa-Rotter, S. Navaneethan, Kei Fukami +13 more
2026Journal of the American Society of Nephrology3 citations Open access
Semantic Scholar
Global availability of medications and health technologies for kidney care: A multinational study from the ISN-GKHA
Dearbhla M Kelly, Erika S W Jones, Z. Barday, Silvia Arruebo +12 more
2025PLOS Global Public Health3 citations Open access
Semantic Scholar
Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New‐User Active Comparator Cohort Study
R. Inoue, Satoko Yamaguchi, A. Okada, Toshimasa Yamauchi +2 more
2025Nephrology3 citations Open access
Semantic Scholar
Effect of SGLT2i on kidney outcomes of individuals with type 2 diabetes according to body mass index: nationwide cohort study
Takahiro Jimba, H. Kaneko, Yuta Suzuki, A. Okada +12 more
2025European Heart Journal - Cardiovascular Pharmacotherapy3 citations Open access
Semantic Scholar
Attribute based cross classification analyses from the BRIGHTEN study reveal that therapeutic responsiveness to erythropoiesis stimulating agents predicts cardiorenal prognosis in renal anemia
Hiroshi Kataoka, T. Hayashi, M. Nangaku, I. Narita +3 more
2025Scientific Reports3 citations Open access
Semantic Scholar
SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation study
Tatsuhiko Azegami, H. Kaneko, A. Okada, Yuta Suzuki +13 more
2026Diabetes, obesity and metabolism2 citations Open access
Semantic Scholar
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure
R. Agarwal, R. Correa-Rotter, S. Navaneethan, H. Heerspink +13 more
2026HYPERTENSION2 citations Open access
Semantic Scholar
PHEX protein in the parathyroid gland contributes to phosphate sensing.
Koki Irie, H. Kato, Natsuho Adachi, Soichiro Kimura +7 more
2025Journal of Clinical Endocrinology and Metabolism2 citations
Semantic Scholar
Using One-Shot Prompting of Non-Fine-Tuned Commercial Artificial Intelligence to Assess Nutrients from Photographs of Japanese Meals
Yuexiang Ji, K. Waki, T. Yamauchi, M. Nangaku +1 more
2025Journal of Diabetes Science and Technology2 citations Open access
Semantic Scholar
Dietary Fiber Estimate of DialBetesPlus App Users: Secondary Analysis of Data From a Randomized Controlled Trial
W. Sze, K. Waki, Ryohei Nakada, Toshimasa Yamauchi +2 more
2025JMIR Formative Research2 citations Open access
Semantic Scholar
Preoperative rehabilitation and in-hospital mortality in delayed hip fracture surgery: a nationwide cohort study with stratification by kidney function
A. Okada, Akira Honda, Satoko Yamaguchi, R. Inoue +5 more
2025BMC Geriatrics2 citations Open access
Semantic Scholar
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Doreen Zhu, P. Judge, Susan T. Francis, Zhao-Jing Che +30 more
2025American Journal of Kidney Diseases2 citations Open access
Semantic Scholar
Sodium Polystyrene Sulfonate and Heart Failure Risk: A Comparative Study With Calcium Polystyrene Sulfonate
Takashin Nakayama, H. Kaneko, Yuta Suzuki, A. Okada +10 more
2025Nephrology2 citations Open access
Semantic Scholar
Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE Trial.
R. Agarwal, J. Green, H. Heerspink, J. Mann +11 more
2026Nephrology, Dialysis and Transplantation1 citations Open access
Semantic Scholar
Digital Intervention Increasing Sleep Duration Among People With Type 2 Diabetes: Pilot Randomized Controlled Trial.
Ryohei Nakada, Daniel R. Lane, Shuya Iwata, Akihiro Isogawa +17 more
2026Journal of Diabetes Science and Technology1 citations
Semantic Scholar
Predicted Lean Body Mass and the Risk of Adverse Kidney Outcomes in Men.
Yuta Suzuki, H. Kaneko, Tatsuhiko Azegami, A. Okada +11 more
2026Journal of renal nutrition1 citations Open access
Semantic Scholar
Association of Weight Loss With Improvement in Metabolic Status Among People Eligible for the Specific Health Guidance Program
Masachika Nishikawa, Yuta Suzuki, Toshiyuki Ko, Hidehiro Kaneko +13 more
2026Circulation Reports1 citations Open access
Semantic Scholar
Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses
D. Cherney, P. Rossing, M. E. Canziani, M. L. Caramori +11 more
2026Diabetes, obesity and metabolism1 citations Open access
Semantic Scholar
Association between early proteinuria reduction and kidney outcomes in Japanese patients with IgA nephropathy: The Japan Chronic Kidney Disease Database
Yuichiro Yano, H. Nagasu, H. Kanegae, S. Itano +6 more
2026Clinical and Experimental Nephrology1 citations
Semantic Scholar
Early Hemodynamic Safety of Simultaneous Initiation of Finerenone and Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes: The CONFIDENCE Trial.
M. Vaduganathan, Jennifer B. Green, Hiddo J. L. Heerspink, Johannes F. E. Mann +8 more
2026Journal of the American College of Cardiology1 citations Open access
Semantic Scholar
589-P: Using One-Shot Prompting of Fine-Tuned Commercial Artificial Intelligence Models to Assess Nutrients from Photographs of Japanese Meals
Yuexiang Ji, K. Waki, Daniel R. Lane, Toshimasa Yamauchi +2 more
2025Diabetes1 citations
Semantic Scholar
Pyruvate Dehydrogenase and Cellular Metabolism in Calcineurin Inhibitor-Induced Kidney Fibrosis.
Yasuhiro Oda, Hiroshi Nishi, F. Hamano, Teruhiko Yoshida +3 more
2025Journal of the American Society of Nephrology1 citations Open access
Semantic Scholar
Efficacy of FiberMore, an AI-Based mHealth Intervention to Increase Dietary Fiber Intake Among Type 2 Diabetes Patients: Protocol for a Pilot Randomized Controlled Trial
W. Sze, K. Waki, Daniel R. Lane, Kyohei Hasegawa +17 more
2025JMIR Research Protocols1 citations Open access
Semantic Scholar
The increasing burden of mild and moderate anaemia in CKD
Hiroshi Nishi, M. Nangaku
2025Nature Reviews Nephrology1 citations
Semantic Scholar
Digital Therapeutics and Type 2 Diabetes: A Review
K. Waki, Shuya Iwata, Toshimasa Yamauchi, M. Nangaku +1 more
2025Journal of Asian Pacific Society of Cardiology1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Okada×14
Invite
A. Okada — researcher profile on SciRah
H. Heerspink×11
Invite
H. Heerspink — researcher profile on SciRah
Tatsuhiko Azegami×11
Invite
Tatsuhiko Azegami — researcher profile on SciRah
Yuta Suzuki×11
Invite
Yuta Suzuki — researcher profile on SciRah

×11

Invite

N. Takeda — researcher profile on SciRah

Invite

H. Morita — researcher profile on SciRah

Invite

N. Takeda — researcher profile on SciRah

H. Yasunaga×11

Invite

H. Yasunaga — researcher profile on SciRah

Kaori Hayashi×11

Invite

Kaori Hayashi — researcher profile on SciRah

Invite

J. McGill — researcher profile on SciRah

Invite

K. Fujiu — researcher profile on SciRah

Invite

K. Node — researcher profile on SciRah